# MSA Safety Inc: financial statements, quarterly MSA · NYSE · CIK 66570 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/msa.md) · [Financials](/companies/msa/financials.md) · [Filings](/companies/msa/filings.md) · [Insiders](/companies/msa/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/msa/financials.md?period=annual). ## Income statement | Line item | Unit | Q1 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [447](/filings/0000066570-25-000007.md) | [495](/filings/0000066570-25-000007.md) | [413](/filings/0000066570-26-000005.md) | [462](/filings/0000066570-26-000005.md) | [433](/filings/0000066570-26-000005.md) | [500](/filings/0000066570-26-000005.md) | [421](/filings/0000066570-26-000012.md) | [474](/filings/0000066570-26-000027.md) | [468](/filings/0000066570-26-000005.md) | [511](/filings/0000066570-26-000005.md) | [464](/filings/0000066570-26-000012.md) | [503](/filings/0000066570-26-000027.md) | | Cost of revenue | $m | [228](/filings/0000066570-24-000045.md) | [257 d](/filings/0000066570-26-000005.md) | [218](/filings/0000066570-25-000016.md) | [239](/filings/0000066570-25-000030.md) | [225](/filings/0000066570-25-000042.md) | [265 d](/filings/0000066570-26-000005.md) | [228](/filings/0000066570-26-000012.md) | [253](/filings/0000066570-26-000027.md) | [251](/filings/0000066570-25-000042.md) | [272 d](/filings/0000066570-26-000005.md) | [244](/filings/0000066570-26-000012.md) | [254](/filings/0000066570-26-000027.md) | | Gross profit | $m | [219](/filings/0000066570-25-000007.md) | [238](/filings/0000066570-25-000007.md) | [196](/filings/0000066570-26-000005.md) | [223](/filings/0000066570-26-000005.md) | [207](/filings/0000066570-26-000005.md) | [234](/filings/0000066570-26-000005.md) | [193](/filings/0000066570-26-000012.md) | [221](/filings/0000066570-26-000027.md) | [218](/filings/0000066570-26-000005.md) | [239](/filings/0000066570-26-000005.md) | [220](/filings/0000066570-26-000012.md) | [249](/filings/0000066570-26-000027.md) | | Research and development | $m | [17.7](/filings/0000066570-24-000045.md) | [19.1 d](/filings/0000066570-26-000005.md) | [15.9](/filings/0000066570-25-000016.md) | [17.1](/filings/0000066570-25-000030.md) | [16.7](/filings/0000066570-25-000042.md) | [16.8 d](/filings/0000066570-26-000005.md) | [15.7](/filings/0000066570-26-000012.md) | [17.0](/filings/0000066570-26-000027.md) | [16.5](/filings/0000066570-25-000042.md) | [16.2 d](/filings/0000066570-26-000005.md) | [16.4](/filings/0000066570-26-000012.md) | [19.2](/filings/0000066570-26-000027.md) | | Selling, general and administrative | $m | [102](/filings/0000066570-24-000045.md) | [107 d](/filings/0000066570-26-000005.md) | [94.2](/filings/0000066570-25-000016.md) | [105](/filings/0000066570-25-000030.md) | [95.1](/filings/0000066570-25-000042.md) | [100 d](/filings/0000066570-26-000005.md) | [94.0](/filings/0000066570-26-000012.md) | [112](/filings/0000066570-26-000027.md) | [103](/filings/0000066570-25-000042.md) | [105 d](/filings/0000066570-26-000005.md) | [108](/filings/0000066570-26-000012.md) | [114](/filings/0000066570-26-000027.md) | | Operating income | $m | [94.1](/filings/0000066570-24-000045.md) | [102 d](/filings/0000066570-26-000005.md) | [80.1](/filings/0000066570-25-000016.md) | [99.9](/filings/0000066570-25-000030.md) | [91.5](/filings/0000066570-25-000042.md) | [118 d](/filings/0000066570-26-000005.md) | [77.8](/filings/0000066570-26-000012.md) | [85.9](/filings/0000066570-26-000027.md) | [94.3](/filings/0000066570-25-000042.md) | [114 d](/filings/0000066570-26-000005.md) | [93.0](/filings/0000066570-26-000012.md) | [112](/filings/0000066570-26-000027.md) | | Interest expense | $m | [12.5](/filings/0000066570-23-000043.md) | [9.6 d](/filings/0000066570-24-000008.md) | [10.7](/filings/0000066570-24-000022.md) | [9.7](/filings/0000066570-24-000037.md) | [9.2](/filings/0000066570-25-000042.md) | [7.3 d](/filings/0000066570-26-000005.md) | [6.8](/filings/0000066570-26-000012.md) | [8.1](/filings/0000066570-26-000027.md) | [8.4](/filings/0000066570-25-000042.md) | [8.4 d](/filings/0000066570-26-000005.md) | [7.7](/filings/0000066570-26-000012.md) | [8.0](/filings/0000066570-26-000027.md) | | Income tax | $m | [22.4](/filings/0000066570-24-000045.md) | [22.9 d](/filings/0000066570-26-000005.md) | [17.5](/filings/0000066570-25-000016.md) | [22.2](/filings/0000066570-25-000030.md) | [21.5](/filings/0000066570-25-000042.md) | [28.9 d](/filings/0000066570-26-000005.md) | [18.3](/filings/0000066570-26-000012.md) | [20.0](/filings/0000066570-26-000027.md) | [22.8](/filings/0000066570-25-000042.md) | [26.3 d](/filings/0000066570-26-000005.md) | [21.7](/filings/0000066570-26-000012.md) | [25.2](/filings/0000066570-26-000027.md) | | Net income | $m | [65.3](/filings/0000066570-25-000007.md) | [76.4](/filings/0000066570-25-000007.md) | [58.1](/filings/0000066570-26-000005.md) | [72.2](/filings/0000066570-26-000005.md) | [66.6](/filings/0000066570-26-000005.md) | [87.9](/filings/0000066570-26-000005.md) | [59.6](/filings/0000066570-26-000012.md) | [62.8](/filings/0000066570-26-000027.md) | [69.6](/filings/0000066570-26-000005.md) | [86.9](/filings/0000066570-26-000005.md) | [71.3](/filings/0000066570-26-000012.md) | [86.2](/filings/0000066570-26-000027.md) | | Diluted EPS | $ per share | [1.65](/filings/0000066570-25-000007.md) | [1.93](/filings/0000066570-25-000007.md) | [1.47](/filings/0000066570-26-000005.md) | [1.83](/filings/0000066570-26-000005.md) | [1.69](/filings/0000066570-26-000005.md) | [2.22](/filings/0000066570-26-000005.md) | [1.51](/filings/0000066570-26-000012.md) | [1.59](/filings/0000066570-26-000027.md) | [1.77](/filings/0000066570-26-000005.md) | [2.21](/filings/0000066570-26-000005.md) | [1.83](/filings/0000066570-26-000012.md) | [2.23](/filings/0000066570-26-000027.md) | | Basic EPS | $ per share | [1.66](/filings/0000066570-25-000007.md) | [1.94](/filings/0000066570-25-000007.md) | [1.48](/filings/0000066570-26-000005.md) | [1.83](/filings/0000066570-26-000005.md) | [1.69](/filings/0000066570-26-000005.md) | [2.23](/filings/0000066570-26-000005.md) | [1.51](/filings/0000066570-26-000012.md) | [1.60](/filings/0000066570-26-000027.md) | [1.78](/filings/0000066570-26-000005.md) | [2.22](/filings/0000066570-26-000005.md) | [1.83](/filings/0000066570-26-000012.md) | [2.23](/filings/0000066570-26-000027.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q1 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [164](/filings/0000066570-24-000045.md) | [146](/filings/0000066570-26-000005.md) | [148](/filings/0000066570-25-000016.md) | [147](/filings/0000066570-25-000030.md) | [154](/filings/0000066570-25-000042.md) | [165](/filings/0000066570-26-000005.md) | [171](/filings/0000066570-26-000012.md) | [147](/filings/0000066570-26-000027.md) | [170](/filings/0000066570-25-000042.md) | [165](/filings/0000066570-26-000027.md) | [180](/filings/0000066570-26-000012.md) | [200](/filings/0000066570-26-000027.md) | | Current assets | $m | [852](/filings/0000066570-23-000043.md) | [786](/filings/0000066570-25-000007.md) | [793](/filings/0000066570-24-000022.md) | [861](/filings/0000066570-24-000037.md) | [843](/filings/0000066570-24-000045.md) | [803](/filings/0000066570-26-000005.md) | [823](/filings/0000066570-25-000016.md) | [887](/filings/0000066570-25-000030.md) | [895](/filings/0000066570-25-000042.md) | [869](/filings/0000066570-26-000027.md) | [892](/filings/0000066570-26-000012.md) | [935](/filings/0000066570-26-000027.md) | | Total assets | $m | [2,194](/filings/0000066570-23-000043.md) | [2,170](/filings/0000066570-26-000005.md) | [2,174](/filings/0000066570-25-000016.md) | [2,244](/filings/0000066570-25-000030.md) | [2,242](/filings/0000066570-25-000042.md) | [2,206](/filings/0000066570-26-000005.md) | [2,236](/filings/0000066570-26-000012.md) | [2,550](/filings/0000066570-26-000027.md) | [2,554](/filings/0000066570-25-000042.md) | [2,554](/filings/0000066570-26-000027.md) | [2,564](/filings/0000066570-26-000012.md) | [2,602](/filings/0000066570-26-000027.md) | | Current liabilities | $m | [325](/filings/0000066570-23-000043.md) | [333](/filings/0000066570-25-000007.md) | [317](/filings/0000066570-24-000022.md) | [352](/filings/0000066570-24-000037.md) | [314](/filings/0000066570-24-000045.md) | [288](/filings/0000066570-26-000005.md) | [280](/filings/0000066570-25-000016.md) | [285](/filings/0000066570-25-000030.md) | [290](/filings/0000066570-25-000042.md) | [289](/filings/0000066570-26-000027.md) | [281](/filings/0000066570-26-000012.md) | [289](/filings/0000066570-26-000027.md) | | Total liabilities | $m | [1,326](/filings/0000066570-23-000043.md) | [1,203](/filings/0000066570-25-000007.md) | [1,180](/filings/0000066570-24-000022.md) | [1,210](/filings/0000066570-24-000037.md) | [1,147](/filings/0000066570-24-000045.md) | [1,062](/filings/0000066570-26-000005.md) | [1,046](/filings/0000066570-25-000016.md) | [1,298](/filings/0000066570-25-000030.md) | [1,251](/filings/0000066570-25-000042.md) | [1,187](/filings/0000066570-26-000027.md) | [1,209](/filings/0000066570-26-000012.md) | [1,200](/filings/0000066570-26-000027.md) | | Long-term debt | $m | [716](/filings/0000066570-23-000043.md) | [575](/filings/0000066570-25-000007.md) | [570](/filings/0000066570-24-000022.md) | [562](/filings/0000066570-24-000037.md) | [528](/filings/0000066570-24-000045.md) | [482](/filings/0000066570-26-000005.md) | [469](/filings/0000066570-25-000016.md) | [671](/filings/0000066570-25-000030.md) | [620](/filings/0000066570-25-000042.md) | [573](/filings/0000066570-26-000027.md) | [605](/filings/0000066570-26-000012.md) | [592](/filings/0000066570-26-000027.md) | | Current portion of debt | $m | [26.2](/filings/0000066570-23-000043.md) | [26.5](/filings/0000066570-25-000007.md) | [26.5](/filings/0000066570-24-000022.md) | [26.5](/filings/0000066570-24-000037.md) | [26.9](/filings/0000066570-24-000045.md) | [26.4](/filings/0000066570-26-000005.md) | [32.9](/filings/0000066570-25-000016.md) | [8.4](/filings/0000066570-25-000030.md) | [8.2](/filings/0000066570-25-000042.md) | [8.2](/filings/0000066570-26-000027.md) | [8.1](/filings/0000066570-26-000012.md) | [8.1](/filings/0000066570-26-000027.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [869](/filings/0000066570-23-000043.md) | [967](/filings/0000066570-25-000007.md) | [995](/filings/0000066570-24-000022.md) | [1,034](/filings/0000066570-24-000037.md) | [1,095](/filings/0000066570-24-000045.md) | [1,143](/filings/0000066570-26-000005.md) | [1,190](/filings/0000066570-25-000016.md) | [1,253](/filings/0000066570-25-000030.md) | [1,302](/filings/0000066570-25-000042.md) | [1,367](/filings/0000066570-26-000027.md) | [1,355](/filings/0000066570-26-000012.md) | [1,402](/filings/0000066570-26-000027.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [125 d](/filings/0000066570-24-000045.md) | [159 d](/filings/0000066570-26-000005.md) | [50.9](/filings/0000066570-25-000016.md) | [53.3 d](/filings/0000066570-25-000030.md) | [84.3 d](/filings/0000066570-25-000042.md) | [108 d](/filings/0000066570-26-000005.md) | [61.8](/filings/0000066570-26-000012.md) | [67.2 d](/filings/0000066570-26-000027.md) | [112 d](/filings/0000066570-25-000042.md) | [122 d](/filings/0000066570-26-000005.md) | [75.7](/filings/0000066570-26-000012.md) | [95.4 d](/filings/0000066570-26-000027.md) | | Capital expenditure | $m | [12.7 d](/filings/0000066570-24-000045.md) | [11.8 d](/filings/0000066570-26-000005.md) | [11.2](/filings/0000066570-25-000016.md) | [14.3 d](/filings/0000066570-25-000030.md) | [14.3 d](/filings/0000066570-25-000042.md) | [14.4 d](/filings/0000066570-26-000005.md) | [10.8](/filings/0000066570-26-000012.md) | [29.3 d](/filings/0000066570-26-000027.md) | [12.0 d](/filings/0000066570-25-000042.md) | [16.3 d](/filings/0000066570-26-000005.md) | [10.6](/filings/0000066570-26-000012.md) | [12.7 d](/filings/0000066570-26-000027.md) | | Dividends paid | $m | [18.5 d](/filings/0000066570-24-000045.md) | [18.5 d](/filings/0000066570-26-000005.md) | [18.5](/filings/0000066570-25-000016.md) | [20.1 d](/filings/0000066570-25-000030.md) | [20.1 d](/filings/0000066570-25-000042.md) | [20.1 d](/filings/0000066570-26-000005.md) | [20.0](/filings/0000066570-26-000012.md) | [20.8 d](/filings/0000066570-26-000027.md) | [20.8 d](/filings/0000066570-25-000042.md) | [20.7 d](/filings/0000066570-26-000005.md) | [20.6](/filings/0000066570-26-000012.md) | [20.9 d](/filings/0000066570-26-000027.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q1 FY2023 (2023-06-30) | Q1 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [39.3](/filings/0000066570-23-000043.md) | [39.2](/filings/0000066570-24-000022.md) | [39.4](/filings/0000066570-24-000037.md) | [39.5](/filings/0000066570-24-000045.md) | [39.6](/filings/0000066570-25-000016.md) | [39.5](/filings/0000066570-25-000030.md) | [39.5](/filings/0000066570-25-000042.md) | [39.5](/filings/0000066570-26-000012.md) | [39.4](/filings/0000066570-26-000027.md) | [39.3](/filings/0000066570-25-000042.md) | [39.0](/filings/0000066570-26-000012.md) | [38.7](/filings/0000066570-26-000027.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 38,578,289 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0000066570-26-000027.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.